We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$27.1B
AUM Growth
+$3.44B
Cap. Flow
+$921M
Cap. Flow %
3.4%
Top 10 Hldgs %
34.67%
Holding
1,351
New
69
Increased
716
Reduced
273
Closed
50

Top Sells

Rank Stock Value
1
OHI icon
Omega Healthcare
OHI
+$137M
2
AMT icon
American Tower
AMT
+$116M
3
PSA icon
Public Storage
PSA
+$97.9M
4
UDR icon
UDR
UDR
+$80.4M
5
AVB icon
AvalonBay Communities
AVB
+$73.9M

Sector Composition

Rank Sector Weight
1 Real Estate 30.73%
2 Technology 27.75%
3 Communication Services 10.3%
4 Consumer Discretionary 6.75%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVXL icon
1176
Anavex Life Sciences
AVXL
$237M
$3K ﹤0.01%
314
COGT icon
1177
Cogent Biosciences
COGT
$6.73B
$3K ﹤0.01%
416
ELVN icon
1178
Enliven Therapeutics
ELVN
$3.78B
$3K ﹤0.01%
152
GERN icon
1179
Geron
GERN
$924M
$3K ﹤0.01%
2,247
GMAB icon
1180
Genmab
GMAB
$17.9B
$3K ﹤0.01%
159
HROW icon
1181
Harrow
HROW
$1.37B
$3K ﹤0.01%
110
MLYS icon
1182
Mineralys Therapeutics
MLYS
$2.36B
$3K ﹤0.01%
234
+82
+54% +$1.19K
NRIX icon
1183
Nurix Therapeutics
NRIX
$2.39B
$3K ﹤0.01%
245
ORIC icon
1184
Oric Pharmaceuticals
ORIC
$1.23B
$3K ﹤0.01%
249
PRAX icon
1185
Praxis Precision Medicines
PRAX
$8.26B
$3K ﹤0.01%
62
PSNL icon
1186
Personalis
PSNL
$1.26B
$3K ﹤0.01%
400
SNDX icon
1187
Syndax Pharmaceuticals
SNDX
$1.73B
$3K ﹤0.01%
314
SYRE icon
1188
Spyre Therapeutics
SYRE
$8.29B
$3K ﹤0.01%
206
WVE icon
1189
Wave Life Sciences
WVE
$1.13B
$3K ﹤0.01%
503
LENZ
1190
LENZ Therapeutics
LENZ
$179M
$3K ﹤0.01%
91
ABSI icon
1191
Absci
ABSI
$1.2B
$2K ﹤0.01%
600
AMLX icon
1192
Amylyx Pharmaceuticals
AMLX
$2.18B
$2K ﹤0.01%
266
ANAB icon
1193
AnaptysBio
ANAB
$1.57B
$2K ﹤0.01%
105
AQST icon
1194
Aquestive Therapeutics
AQST
$462M
$2K ﹤0.01%
500
ARVN icon
1195
Arvinas
ARVN
$523M
$2K ﹤0.01%
252
CGEM icon
1196
Cullinan Oncology
CGEM
$1.06B
$2K ﹤0.01%
218
CRMD icon
1197
CorMedix
CRMD
$578M
$2K ﹤0.01%
200
CRVS icon
1198
Corvus Pharmaceuticals
CRVS
$1.08B
$2K ﹤0.01%
400
CSTL icon
1199
Castle Biosciences
CSTL
$743M
$2K ﹤0.01%
86
DAWN
1200
DELISTED
Day One Biopharmaceuticals
DAWN
$2K ﹤0.01%
296

Similar funds

Daiwa Securities Group's Q2 2025 Portfolio in Review

As of Q2 2025, Daiwa Securities Group held 1,351 positions worth $27.1B, up 15% from $23.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $921M of net new capital in Q2 2025, opening 69 new positions and adding to 716 existing holdings. Its largest new stake was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.

By sector, the portfolio is most concentrated in Real Estate at 31% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Omega Healthcare, an estimated $137M trimmed.

  • Daiwa Securities Group's largest Q2 2025 buy was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.
  • Daiwa Securities Group added most to Apple in Q2 2025, an estimated $162M increase.
  • Daiwa Securities Group's biggest Q2 2025 reduction was Omega Healthcare, cutting an estimated $137M.
  • Daiwa Securities Group fully exited iShares Core US Aggregate Bond ETF in Q2 2025, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $27.1B portfolio in Q2 2025.
  • Daiwa Securities Group opened 69 new positions and closed 50 in Q2 2025.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $27.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2025, filed 14 Aug 2025.